Tony-winnende Broadway-toneelschrijver gediagnosticeerd met lvPPA 

Playwright Christopher Durang was Diagnosed with lvPPA in 2016

Christopher Durang, a playwright renowned for his absurdist and comedic writing style, has quietly backed away from producing plays after receiving a diagnosis of logopenic variant primary progressive aphasia (lvPPA). 

Revealing his diagnosis to Broadway-nieuws earlier this year, Durang’s family and friends said that the first signs began to show in 2012. Durang was officially diagnosed with lvPPA in 2016.  

“He was complaining about word-finding difficulty,” said Murray Grossman, MD, a member of AFTD’s Medical Advisory Council. “For somebody who writes plays, that’s a big deal and it’s something that’s easy to notice.” 

At first, Durang was able to continue pursuing his craft, albeit at a much slower pace than before. After retiring from Julliard, Durang penned the play Turning Off the Morning News, which premiered in 2018. Durang’s final play, Harriet and Other Horrible People, was written shortly after, but has yet to be produced on stage.  

Durang was a participant in a clinical trial using transcranial direct current stimulation therapy on affected areas of the brain. though it didn’t appear that the procedure made any difference.  

As Dr. Grossman points out, much research and testing is currently being done on potential treatments. “[There are] a couple of antibodies that are in the pipeline that are likely [to have positive results], and then we can start writing a prescription for people like Chris with logopenic PPA,” Grossman said.  

Primaire progressieve afasie is a form of FTD that primarily affects communication, though the pathology of lvPPA is almost always caused by Alzheimer’s disease.

Do you have questions about lvPPA? AFTD’s HelpLine can answer your questions and provide tailored guidance to help you handle the disease – contact the HelpLine at 1-866-507-7222 of info@theaftd.org

Blijf geïnformeerd

color-icon-laptop

Meld u nu aan en blijf op de hoogte van het laatste nieuws met onze nieuwsbrief, evenementwaarschuwingen en meer...